tissue drug levels. The patient was an Australian Shepherd, who tested positive for multi -drug resistant gene (mdr1) mutation, which codes for the P-glycoprotein membrane transport molecule. This gene mutation disables the active removal of toxins through the blood-brain-barrier in this breed, explaining the long recovery for this patient. SPLD was efficient to decrease the amount of ivermectin with a relatively small dialysis dose (Kt/V of 0.7%) by 29 %. The normal plasma clearance in dogs is 2% per hour. This patient was initially treated with intravenous lipid therapy, which might have decreased the extracorporeal ivermectin reduction ratio. SPLD was an effective way to decrease the plasma levels of ivermectin in this patient. The lack of fast clinical response to the decreased plasma levels can partly be explained by the mdr1 gene mutation, which decreased the patient's ability of actively removing the drug from the brain tissue.
tissue drug levels. The patient was an Australian Shepherd, who tested positive for multi -drug resistant gene (mdr1) mutation, which codes for the P-glycoprotein membrane transport molecule. This gene mutation disables the active removal of toxins through the blood-brain-barrier in this breed, explaining the long recovery for this patient. SPLD was efficient to decrease the amount of ivermectin with a relatively small dialysis dose (Kt/V of 0.7%) by 29 %. The normal plasma clearance in dogs is 2% per hour. This patient was initially treated with intravenous lipid therapy, which might have decreased the extracorporeal ivermectin reduction ratio. SPLD was an effective way to decrease the plasma levels of ivermectin in this patient. The lack of fast clinical response to the decreased plasma levels can partly be explained by the mdr1 gene mutation, which decreased the patient's ability of actively removing the drug from the brain tissue.
Type B lacTic acidosis secondary To Thiamine deficiency in a child wiTh malignancy
Mashael Alqahtani 1 , Eric Wald 2 ; 1 Ann & Robert H Lurie Children's Hospital, Chicago, IL, 2 Northwestern University Feinberg School of Medicine, Chicago, IL introduction: Type B lactic acidosis is a high-anion gap metabolic acidosis that occurs in the absence of tissue hypoxia. It involves the underutilization of lactate or compromised lactate metabolism. Liver disease, pyruvate dehydrogenase (thiamine) deficiency, inhibition of gluconeogenesis, and uncoupling of oxidative phosphorylation are the most common causes. We present a 4-year-old Caucasian male with medulloblastoma s/p resection undergoing treatment with Vincristine, proton beam therapy and steroids. He presented to the PICU with presumed septic shock that was treated with fluids, vasopressors, antibiotics and stress dose steroids. He was neutropenic and exhibited low-grade DIC. He demonstrated high-output renal failure with electrolyte wasting despite treatment. His mentation was impaired. His initial pH was 7.25 and his lactate ranged between10-12 mEq/L. An abdominal radiograph on admission was suggestive of pneumatosis. A subsequent CT scan of the abdomen did not reveal significant bowel inflammation or perforation. The patient improved and vasopressor support was stopped after 48 hours, yet his lactic acidosis persisted. Lactate levels peaked hospital day 3 at 19 mEq/L in the absence of hypoperfusion and was accompanied by profound hyperglycemia. A concomitant abdominal radiograph was suspicious for free air so the patient underwent exploratory laparoscopy that did not show evidence of ischemia or perforation. Because a type B lactic acidosis was suspected, intravenous thiamine and L-carnitine were given empirically and the lactate normalized over several hours, as did his urine output, and his mentation. Thiamine activity levels (transketolase activity in red blood cells) were not determined pre-therapy. The lactate/pyruvate ratio decreased to 10 from 20 after treatment. His risk factors for thiamine deficiency included malignancy, intractable emesis, and need for chronic total parenteral nutrition (TPN), which lacked MVI for several weeks due to national shortage. Thiamine is a cofactor for pyruvate dehydrogenase, which is a key enzyme in the anaerobic oxidation of glucose. The most dangerous sequela of thiamine deficiency is the CNS injury (Wernicke-Korsakoff syndrome). This patient recovered fully, finished his radiation therapy during his hospital course and was discharged. Patients receiving TPN without MVI supplementation are at risk for thiamine deficiency and its associated life-threatening complications.
fool me once, shame on you. fool me Twice, shame on me. -refracTory hypoTension: a conundrum
Yuhann Lopez 1 , Sudhir Krishnan 1 ; 1 Cleveland Clinic Foundation, Cleveland, OH introduction: Diagnosing factitious disorders can be expensive, time consuming, and challenging. We present a clinical conundrum of refractory hypotension that ultimately led to a diagnosis of surreptitious AV-nodal agent abuse. Case: A 41 year-old female with a diagnosis of idiopathic capillary leak syndrome (ICLS), s/p demand pacemaker for intermittent symptomatic bradycardia, was admitted for elective administration of intravenous immunoglobulin (IVIG). Development of hypoalbuminemia, bilateral pleural effusion, and peripheral edema on a background of refractory hypotension during a preceding hospital admission (6 months prior to the index admission) aided the diagnosis of ICLS [1]. A diagnosis of ICLS was made following an extensive 2-year evaluation by multiple specialties for a constellation of symptoms that had escaped clinical diagnosis. She was committed to IVIG, after failure of first line therapy (Terbutaline) [2] by an autonomic dysfunction expert, in consultation with an allergist, pulmonologist, general cardiologist, and electrophysiologist. On evaluation, her physical examination, biochemical profile, echocardiogram, pacemaker evaluation, and radiology were all unremarkable. Within one hour of admission, the patient developed acute refractory hypotension and bradycardia prompting pacemaker activation and vasopressors. Hemodynamic improvement noted during the course of the day was followed by a precipitous decline at night, only to improve dramatically again with short periods of vasopressor therapy. This was the pattern of her clinical course during her admission. Inconsistencies in her clinical presentation (no evidence of hemoconcentration or third spacing -a hallmark of ICLS) and intermittent pacemaker activation for bradycardia, prompted a reevaluation of her clinical diagnosis. The evanescent nature of the symptoms in an otherwise healthy individual was intriguing. Our belief in the medical adage 'All other things being equal the simplest answer is usually the best' prompted us to consider surreptitious AV-nodal blocker abuse. We requested serum beta and calcium-channel blocker levels during the throes of these acute hypotensive episodes while the patient was on norepinephrine. A two year search for a medical dilemma that escaped clinical diagnosis came to fruitition when a Metoprolol level of 95 ng/ml (therapeutic limit 20 to 340 ng/ml) and a Verapamil level of 380 ng/ml (therapeutic limit 70 to 350 ng/ ml) was reported. A case for Munchausen's Syndrome -Factitious disorder was thus made. Patient was confronted with the data and reluctantly admitted to surreptitious use of Metoprolol and Verapamil. She elected to have her pacemaker removed and psychiatry services were consulted. Discussion: Factitious Disorder is a mental disorder in which a person acts as if he or she has a physical or mental illness when, in fact, he or she has consciously created their symptoms. Idiopathic capillary leak syndrome is a rare disease of unknown cause. It results in reversible plasma extravasation and vascular collapse. Diagnosis is made clinically and by exclusion of other diseases that cause similar signs and symptoms [1] . Factitious disorders must also be considered as part of the differential diagnosis when there are inconsistencies in the patient's history, laboratory tests, and physical examination findings [3] . conclusion: Factitious disorders could be the simplest explanation for medical conundrums that baffle physicians. "When you hear hoofbeats, think horses, not zebras. introduction: Beta-adrenergic antagonist toxicity causes cardiovascular collapse often refractory to standard therapy. Alternative therapies include high-dose insulin, lipid emulsion and venoarterial extracorporeal membrane oxygenation (VA-ECMO). Case: A 47-year-old male ingested 10 grams of metoprolol tartrate (100 x 100 mg) in a suicide attempt. He was alert upon EMS arrival, 60 minutes after ingestion. He lost consciousness en route to the emergency department (ED) and on presentation, he was comatose, with bradycardia and hypotension. He was intubated using ketamine (80 mg IV) and rocuronium (80 mg IV). Both glucagon (14 mg IV) and vasopressor support (epinephrine 0.1 mcg/kg/ min, dobutamine 10 mcg/kg/min) were administered. Despite these therapies, he developed cardiac arrest for 55 minutes, requiring ACLS (epinephrine 5 mg IV and vasopressin 40 units IV) with multiple episodes of ROSC. Additional vasopressor administration (vasopressin 0.04 U/min, norepinephrine 0.5 mcg/kg/ min) did not improve his hemodynamics. High-dose, regular insulin (250 units IV) and 20% lipid emulsion (1.5 ml/kg IV bolus, 0.25ml/kg for 30 minutes) were administered and VA-ECMO was initiated. The patient's hemodynamics then improved. His neurologic examination demonstrated no pupillary, cough, gag or corneal reflexes and no motor response. Therapeutic hypothermia was initiated. He awoke 10 hours after presentation and was gradually rewarmed. VA-ECMO was discontinued on hospital day (HD) 3, and the patient was discharged on HD 10 with excellent neurologic recovery. A serum metoprolol level measured 25,000 ng/mL (therapeutic 20-340 ng/mL). Discussion: High-dose insulin can be beneficial in beta-adrenergic antagonist cardiotoxicity, increasing inotropy through augmented intracellular glucose transport. Lipid emulsion is thought to act as a lipid extractor, lowering serum and tissue levels. VA-ECMO was used with the above therapies, restoring vital organ perfusion and allowing intrinsic drug metabolism and elimination. High-dose insulin, lipid emulsion and VA-ECMO should be considered for refractory cardiac arrest secondary to beta-adrenergic antagonist toxicity such as metoprolol.
paroxysmal sympaTheTic hyperacTiViTy in hemispheric inTraparenchymal hemorrhage
Billy Gao 1 , Jeffrey Pollock 2 , Holly Hinson 1 ; 1 N/A, Portland, OR, 2 OHSU, Portland, OR introduction: Paroxysmal Sympathetic Hyperactivity (PSH) is a hyperadrenergic syndrome that may follow any type of acute brain injury. The pathophysiology
